Overview

Efficacy and Safety Assessment of Intracameral Injection of T2380 in Cataract Surgery

Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine the efficacy and safety assessment of T2380 for mydriasis and anaesthesia in phacoemulsification cataract surgery versus reference group (topical mydriatics and anaesthetic) 2X246 patients.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Laboratoires Thea
Treatments:
Anesthetics
Mydriatics
Tetracaine
Tropicamide
Criteria
Inclusion Criteria:

- Signed and dated informed consent

- Male or female aged from 40 to 88 years old

- Scheduled to undergo unilateral cataract surgery

Exclusion criteria:

- Combined surgery

- Previous intraocular surgery